U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07557225) titled '18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors' on April 22.
Brief Summary: The goal of this clinical trial is to evaluate the diagnostic value of CAIX protein specific probe 18F-T2 in PET/CT imaging in participants with solid tumors. It will also assess the safety, tolerability and radiation dosimetry of 18F-T2.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Clear Cell Renal Cell Cancer (ccRCC)
Urothelial Carcinoma (UC)
Colorectal Cancer
Cervical Cancer
Ovarian Cancer
Head and Neck Cancer
Hepatocellular Carcinoma (HCC)
Cholangiocarcinoma
Non Small Cell Lung Cancer
Small Cell Lung Cancer
Breast Cancer...